UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Miniaturized phased-array ultrasound and photoacoustic endoscopic imaging system

Photoacoustics (Munich), 2019-09, Vol.15, p.100139-100139, Article 100139

2019

Volltextzugriff (PDF)

ONC201 induces the unfolded protein response (UPR) in high‐ and low‐grade ovarian carcinoma cell lines and leads to cell death regardless of platinum sensitivity

Cancer medicine (Malden, MA), 2021-05, Vol.10 (10), p.3373-3387

2021

Volltextzugriff (PDF)

Management of squamous cell vulvar cancer: A review

The journal of obstetrics and gynaecology research, 2014-05, Vol.40 (5), p.1217-1225

2014

Volltextzugriff (PDF)

A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006)

Journal of clinical oncology, 2023-01, Vol.41 (2), p.276-284

2023

Volltextzugriff (PDF)

Immune checkpoint expression, microsatellite instability, and mutational burden: Identifying immune biomarker phenotypes in uterine cancer

Gynecologic oncology, 2020-02, Vol.156 (2), p.393-399

2020

Volltextzugriff (PDF)

Merkel cell carcinoma in a patient with noninvasive vulvar Paget's disease

American journal of obstetrics and gynecology, 2012-07, Vol.207 (1), p.e9-e11

2012

Volltextzugriff (PDF)

Molecular profiles of endometrial cancer tumors among Black patients

Gynecologic oncology, 2022-07, Vol.166 (1), p.108-116

2022

Volltextzugriff (PDF)

Hysteroscopic Morcellation in Endometrial Cancer Diagnosis: Increased Risk?

Journal of minimally invasive gynecology, 2021-09, Vol.28 (9), p.1625-1632

2021

Volltextzugriff (PDF)

Lysine Residues Lys-19 and Lys-49 of β-Catenin Regulate Its Levels and Function in T Cell Factor Transcriptional Activation and Neoplastic Transformation

The Journal of biological chemistry, 2006-09, Vol.281 (36), p.26181-26187

2006

Volltextzugriff (PDF)

Chemotherapy of vulvar cancer: a review

Wiener Klinische Wochenschrift, 2013-03, Vol.125 (5-6), p.119-128

2013

Volltextzugriff (PDF)

Clinical and pathologic characteristics of serous carcinoma confined to the endometrium: a multi-institutional study

International journal of gynecological pathology, 2013-03, Vol.32 (2), p.181-187

2013

Volltextzugriff (PDF)

HER2 in Uterine Serous Carcinoma: Testing platforms and implications for targeted therapy

Gynecologic oncology, 2022-11, Vol.167 (2), p.289-294

2022

Volltextzugriff (PDF)

A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor–Positive Ovarian Cancer (Study 006)

Obstetrical & gynecological survey, 2023-06, Vol.78 (6), p.341-342

2023

Volltextzugriff (PDF)

Health disparities among cancer patients who received molecular testing for biomarker-directed therapy

Cancer research communications, 2024-08

2024

Volltextzugriff (PDF)

Lysine Residues Lys-19 and Lys-49 of Î²-Catenin Regulate Its Levels and Function in T Cell Factor Transcriptional Activation and Neoplastic Transformation

The Journal of biological chemistry, 2006-09, Vol.281 (36), p.26181

2006

Volltextzugriff (PDF)

A Randomized Phase 3 Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor Positive Ovarian Cancer

SSRN Electronic Journal

Volltextzugriff (PDF)

CUDC-907, a dual HDAC and PI3K inhibitor, to inhibit cancer progression both in high and low grade ovarian carcinoma cell lines

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e17556-e17556

2018

Volltextzugriff (PDF)

Effective expression of small interfering RNA in human cells

Nature biotechnology, 2002-05, Vol.20 (5), p.505-508

2002

Volltextzugriff (PDF)

Dual-Illumination Ultrasound/ Photoacoustic System for Cervical Cancer Imaging

IEEE photonics journal, 2021-02, Vol.13 (1), p.1-10

2021

Volltextzugriff (PDF)

Concurrent surgery for locoregional gynecologic cancers and pelvic floor disorders in the medicare population (1141)

Gynecologic oncology, 2023-09, Vol.176, p.S101-S102

2023

Volltextzugriff (PDF)

Disparities in adjuvant treatment of high-grade endometrial cancer in the Medicare population

American journal of obstetrics and gynecology, 2022-04, Vol.226 (4), p.541.e1-541.e13

2022

Volltextzugriff (PDF)

Connective tissue growth factor expression maintains the epithelial phenotype of ovarian cancer in early epithelial to mesenchymal transition

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e17544-e17544

2022

Volltextzugriff (PDF)

Incidence and survival of multiple primary cancers in United States women (349)

Gynecologic oncology, 2022-08, Vol.166, p.S178-S179

2022

Volltextzugriff (PDF)

Sudocetaxel zendusortide (TH1902), a novel sortilin-receptor (SORT1)-targeting peptide-drug-conjugate (PDC) in patients (pts) with advanced solid tumors: Results from part 1 (dose-escalation) of a phase 1, open-label study

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.3089-3089

2023

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(82)

Publikationsform

Sprache

Englisch
(102)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Miniaturized phased-array ultrasound and photoacoustic endoscopic imaging system

ONC201 induces the unfolded protein response (UPR) in high‐ and low‐grade ovarian carcinoma cell lines and leads to cell death regardless of platinum sensitivity

Management of squamous cell vulvar cancer: A review

Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial

A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006)

Immune checkpoint expression, microsatellite instability, and mutational burden: Identifying immune biomarker phenotypes in uterine cancer

Merkel cell carcinoma in a patient with noninvasive vulvar Paget's disease

Molecular profiles of endometrial cancer tumors among Black patients

Hysteroscopic Morcellation in Endometrial Cancer Diagnosis: Increased Risk?

Lysine Residues Lys-19 and Lys-49 of β-Catenin Regulate Its Levels and Function in T Cell Factor Transcriptional Activation and Neoplastic Transformation

Chemotherapy of vulvar cancer: a review

Clinical and pathologic characteristics of serous carcinoma confined to the endometrium: a multi-institutional study

HER2 in Uterine Serous Carcinoma: Testing platforms and implications for targeted therapy

A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor–Positive Ovarian Cancer (Study 006)

Health disparities among cancer patients who received molecular testing for biomarker-directed therapy

Lysine Residues Lys-19 and Lys-49 of Î²-Catenin Regulate Its Levels and Function in T Cell Factor Transcriptional Activation and Neoplastic Transformation

A Randomized Phase 3 Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor Positive Ovarian Cancer

CUDC-907, a dual HDAC and PI3K inhibitor, to inhibit cancer progression both in high and low grade ovarian carcinoma cell lines

Effective expression of small interfering RNA in human cells

Dual-Illumination Ultrasound/ Photoacoustic System for Cervical Cancer Imaging

Concurrent surgery for locoregional gynecologic cancers and pelvic floor disorders in the medicare population (1141)

Disparities in adjuvant treatment of high-grade endometrial cancer in the Medicare population

Connective tissue growth factor expression maintains the epithelial phenotype of ovarian cancer in early epithelial to mesenchymal transition

Incidence and survival of multiple primary cancers in United States women (349)

Sudocetaxel zendusortide (TH1902), a novel sortilin-receptor (SORT1)-targeting peptide-drug-conjugate (PDC) in patients (pts) with advanced solid tumors: Results from part 1 (dose-escalation) of a phase 1, open-label study

Suchergebnisse filtern